Back to STATE STREET CORP STATE STREET CORP

AMLXAMLX
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in AMYLYX PHARMACEUTICALS INC

STATE STREET CORP holds 2.6M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $46.8M as of 2026-Q2. The position was increased (+10.2% shares). AMLX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$46.8M

Current Shares

2.6M

Total Value Change

+$46.3M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+10.2%
$46.8M0.0%$17.96
32
2026-Q1
Increased
2.4M
+14.2%
$32.8M0.0%$14.11
33
2025-Q4
Increased
2.1M
+27.7%
$25M0.0%$12.00
36
2025-Q3
Increased
1.6M
+60.7%
$22M0.0%$14.90
41
2025-Q2
Increased
1M
+285.4%
$6.5M0.0%$6.33
44
2025-Q1
Increased
261,783
+19.9%
$926,7120.0%$3.66
20
2024-Q4
Increased
218,383
+41.0%
$825,4880.0%$3.84
22
2024-Q3
Unchanged
154,908
0.0%
$501,9020.0%$3.08
0

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used